J.M. Laboratories: drug alert entries
Batches made by J.M. Laboratories (as named by CDSCO) that appear in CDSCO drug alerts: 11 entries. For spurious entries, the named company may be the brand owner rather than the actual maker.
Olmesartan Medoxomil, Hydrochlorothiazide (OLMIMAT-20AH)NSQ
Result: The sample does not conforms to the claim with respect to Assay of Olmesartan Medoxomil.
Azithromycin & Lactic Acid Bacillus TabletsNSQ
Result: The sample does not conform to claim as per Schedule V of Drug and Cosmetics Act and Rules 1945 with respect to Assay of Lactic Acid Bacillus.
Clopidogrel & Aspirin Tablets (Clopitrust-A 75)NSQ
Result: Free salicylic Acid (12.01%) and Content of Aspirin (77.13%)
Cefuroxime Axetil & Potassium Clavulanate Tablets I.P.NSQ
Result: The sample does not conform to I.P. with respect to the tests of Dissolution and Assay of Cefuroxime and Clavulanic Acid.
(Paracetamol, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Tablets) (Rhinoheal Tablets)NSQ
Result: Description
Pioglitazone Hydrochloride Tablets IP (laoglit-7.5)NSQ
Result: Test for Dissolution
Aceclofenac & Paracetamol Tablets (A-CIL P)NSQ
Result: Description
Calcium Carbonate & Vitamin D3 Tablets IPNSQ
Result: The sample does not conform to claim as per IP 2022 in respect to the Test of Uniformity of content of Vitamin D3
Amoxycillin & Potassium Clavulanate Tablets IP(Amoxheal – 625 )NSQ
Result: The sample does not conform to standard quality in respect of the test for Dissolution & Assay of Amoxycillin performed.
Aceclofenac & Paracetamol TabletsNSQ
Result: It fails the test Dissolution and Assay as per IP.
Calcium Carbonate & Vitamin D3 Tablets I.P (DPCAL-500)NSQ
Result: Test for Dissolution for Calcium and Assay for Vitamin D3